Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity | Patent Number 09278096

US 09278096 B2
Application Number12741780
Publication NumberUS 20110201617 A1
Pendency7 years, 3 months, 28 days
Filled DateNov 12, 2008
Priority DateNov 13, 2007
Publication DateAug 18, 2011
Expiration DateNov 12, 2027
Inventor/ApplicantsMarianne Dragheim
Aneil Batra
Jin Chon
Nicholas Moore
ExaminesSHIAO, REI TSANG
Art Unit1628
Technology Center1600
Assignments
Takeda Pharmaceutical Company Limited
Current
Takeda Pharmaceuticals North AmericaH. Lundbeck As
Original
Takeda Pharmaceutical Company Limited
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.